

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.35414200 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 6.35414200 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.04874600 |
| 4 | L-phenylalanine metabolic process (GO:0006558) | 6.04874600 |
| 5 | aromatic amino acid family catabolic process (GO:0009074) | 5.80633021 |
| 6 | tryptophan catabolic process (GO:0006569) | 5.39031521 |
| 7 | indole-containing compound catabolic process (GO:0042436) | 5.39031521 |
| 8 | indolalkylamine catabolic process (GO:0046218) | 5.39031521 |
| 9 | kynurenine metabolic process (GO:0070189) | 5.22185433 |
| 10 | glyoxylate metabolic process (GO:0046487) | 5.06565620 |
| 11 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.05840199 |
| 12 | tryptophan metabolic process (GO:0006568) | 5.03063047 |
| 13 | lysine catabolic process (GO:0006554) | 4.97987912 |
| 14 | lysine metabolic process (GO:0006553) | 4.97987912 |
| 15 | bile acid biosynthetic process (GO:0006699) | 4.90060305 |
| 16 | alpha-linolenic acid metabolic process (GO:0036109) | 4.68170977 |
| 17 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.67896255 |
| 18 | regulation of isotype switching to IgG isotypes (GO:0048302) | 4.67830161 |
| 19 | heme transport (GO:0015886) | 4.55252329 |
| 20 | epoxygenase P450 pathway (GO:0019373) | 4.51765081 |
| 21 | regulation of triglyceride catabolic process (GO:0010896) | 4.51051590 |
| 22 | amino-acid betaine metabolic process (GO:0006577) | 4.49660102 |
| 23 | short-chain fatty acid metabolic process (GO:0046459) | 4.38555474 |
| 24 | cysteine metabolic process (GO:0006534) | 4.36913242 |
| 25 | urea cycle (GO:0000050) | 4.34106963 |
| 26 | urea metabolic process (GO:0019627) | 4.34106963 |
| 27 | cellular ketone body metabolic process (GO:0046950) | 4.32840488 |
| 28 | sulfur amino acid catabolic process (GO:0000098) | 4.29996956 |
| 29 | serine family amino acid catabolic process (GO:0009071) | 4.29739105 |
| 30 | high-density lipoprotein particle remodeling (GO:0034375) | 4.29625872 |
| 31 | fatty acid beta-oxidation (GO:0006635) | 4.27343304 |
| 32 | bile acid metabolic process (GO:0008206) | 4.18596693 |
| 33 | alpha-amino acid catabolic process (GO:1901606) | 4.17503659 |
| 34 | aromatic amino acid family metabolic process (GO:0009072) | 4.17486973 |
| 35 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.16909434 |
| 36 | protein carboxylation (GO:0018214) | 4.16909434 |
| 37 | regulation of fibrinolysis (GO:0051917) | 4.14259276 |
| 38 | triglyceride homeostasis (GO:0070328) | 4.12380030 |
| 39 | acylglycerol homeostasis (GO:0055090) | 4.12380030 |
| 40 | complement activation, alternative pathway (GO:0006957) | 4.08615616 |
| 41 | omega-hydroxylase P450 pathway (GO:0097267) | 4.06494299 |
| 42 | coenzyme catabolic process (GO:0009109) | 4.05872640 |
| 43 | fatty acid oxidation (GO:0019395) | 4.03988480 |
| 44 | homocysteine metabolic process (GO:0050667) | 4.03704485 |
| 45 | acetyl-CoA metabolic process (GO:0006084) | 4.03348036 |
| 46 | nitrogen cycle metabolic process (GO:0071941) | 4.01849165 |
| 47 | oxidative demethylation (GO:0070989) | 4.01775339 |
| 48 | negative regulation of fibrinolysis (GO:0051918) | 3.98830378 |
| 49 | fatty acid transmembrane transport (GO:1902001) | 3.98346179 |
| 50 | regulation of protein activation cascade (GO:2000257) | 3.97745661 |
| 51 | lipid oxidation (GO:0034440) | 3.96939432 |
| 52 | fatty acid catabolic process (GO:0009062) | 3.96071752 |
| 53 | tyrosine metabolic process (GO:0006570) | 3.92419904 |
| 54 | cellular amino acid catabolic process (GO:0009063) | 3.90111348 |
| 55 | aspartate family amino acid catabolic process (GO:0009068) | 3.89409647 |
| 56 | carnitine shuttle (GO:0006853) | 3.87385150 |
| 57 | monocarboxylic acid catabolic process (GO:0072329) | 3.87276991 |
| 58 | cellular biogenic amine catabolic process (GO:0042402) | 3.83449243 |
| 59 | amine catabolic process (GO:0009310) | 3.83449243 |
| 60 | indolalkylamine metabolic process (GO:0006586) | 3.82864540 |
| 61 | 2-oxoglutarate metabolic process (GO:0006103) | 3.79504732 |
| 62 | glutamate metabolic process (GO:0006536) | 3.78476985 |
| 63 | carnitine metabolic process (GO:0009437) | 3.77206199 |
| 64 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.76607329 |
| 65 | creatine metabolic process (GO:0006600) | 3.74916828 |
| 66 | reverse cholesterol transport (GO:0043691) | 3.74390874 |
| 67 | drug catabolic process (GO:0042737) | 3.71835292 |
| 68 | carboxylic acid catabolic process (GO:0046395) | 3.70984200 |
| 69 | organic acid catabolic process (GO:0016054) | 3.70984200 |
| 70 | ketone body metabolic process (GO:1902224) | 3.70839113 |
| 71 | regulation of complement activation (GO:0030449) | 3.70082284 |
| 72 | negative regulation of lipase activity (GO:0060192) | 3.69888849 |
| 73 | regulation of cholesterol esterification (GO:0010872) | 3.68261734 |
| 74 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.66897425 |
| 75 | cellular modified amino acid catabolic process (GO:0042219) | 3.66642639 |
| 76 | plasma lipoprotein particle remodeling (GO:0034369) | 3.66041727 |
| 77 | protein-lipid complex remodeling (GO:0034368) | 3.66041727 |
| 78 | macromolecular complex remodeling (GO:0034367) | 3.66041727 |
| 79 | iron coordination entity transport (GO:1901678) | 3.63592644 |
| 80 | biotin metabolic process (GO:0006768) | 3.62511660 |
| 81 | branched-chain amino acid catabolic process (GO:0009083) | 3.60854228 |
| 82 | regulation of bile acid biosynthetic process (GO:0070857) | 3.57395086 |
| 83 | ethanol oxidation (GO:0006069) | 3.57086836 |
| 84 | drug transmembrane transport (GO:0006855) | 3.56070911 |
| 85 | regulation of sequestering of triglyceride (GO:0010889) | 3.56061558 |
| 86 | phospholipid efflux (GO:0033700) | 3.55476986 |
| 87 | S-adenosylmethionine metabolic process (GO:0046500) | 3.52768447 |
| 88 | benzene-containing compound metabolic process (GO:0042537) | 3.52595132 |
| 89 | positive regulation of lipid catabolic process (GO:0050996) | 3.51199716 |
| 90 | phospholipid homeostasis (GO:0055091) | 3.48551418 |
| 91 | plasma lipoprotein particle clearance (GO:0034381) | 3.48137497 |
| 92 | cellular glucuronidation (GO:0052695) | 3.48003792 |
| 93 | bile acid and bile salt transport (GO:0015721) | 3.46362600 |
| 94 | oxaloacetate metabolic process (GO:0006107) | 3.41783942 |
| 95 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 3.40930844 |
| 96 | imidazole-containing compound metabolic process (GO:0052803) | 3.40114596 |
| 97 | exogenous drug catabolic process (GO:0042738) | 3.39914422 |
| 98 | glycine metabolic process (GO:0006544) | 3.38888918 |
| 99 | negative regulation of cholesterol transport (GO:0032375) | 3.38254932 |
| 100 | negative regulation of sterol transport (GO:0032372) | 3.38254932 |
| 101 | positive regulation of fatty acid oxidation (GO:0046321) | 3.37102703 |
| 102 | valine metabolic process (GO:0006573) | 3.36271925 |
| 103 | branched-chain amino acid metabolic process (GO:0009081) | 3.35989830 |
| 104 | positive thymic T cell selection (GO:0045059) | 3.28775945 |
| 105 | negative regulation of type 2 immune response (GO:0002829) | 3.28211441 |
| 106 | alkaloid metabolic process (GO:0009820) | 3.26380145 |
| 107 | regulation of lipoprotein particle clearance (GO:0010984) | 3.25435888 |
| 108 | cholesterol efflux (GO:0033344) | 3.23479038 |
| 109 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.22680702 |
| 110 | regulation of activation of Janus kinase activity (GO:0010533) | 3.21881182 |
| 111 | drug metabolic process (GO:0017144) | 3.21578198 |
| 112 | urate metabolic process (GO:0046415) | 3.20892501 |
| 113 | glucuronate metabolic process (GO:0019585) | 3.18634954 |
| 114 | uronic acid metabolic process (GO:0006063) | 3.18634954 |
| 115 | regulation of cholesterol metabolic process (GO:0090181) | 3.17983888 |
| 116 | flavonoid metabolic process (GO:0009812) | 3.17096058 |
| 117 | arginine metabolic process (GO:0006525) | 3.15551287 |
| 118 | cofactor catabolic process (GO:0051187) | 3.14282312 |
| 119 | regulation of phospholipid biosynthetic process (GO:0071071) | 3.00254227 |
| 120 | positive T cell selection (GO:0043368) | 2.95831600 |
| 121 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.89326189 |
| 122 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.88532104 |
| 123 | positive regulation of B cell differentiation (GO:0045579) | 2.82714145 |
| 124 | positive regulation of T-helper 1 type immune response (GO:0002827) | 2.80760296 |
| 125 | regulation of skeletal muscle contraction (GO:0014819) | 2.78330379 |
| 126 | negative regulation of telomerase activity (GO:0051974) | 2.78238851 |
| 127 | phosphatidylcholine acyl-chain remodeling (GO:0036151) | 2.75795954 |
| 128 | blood coagulation, intrinsic pathway (GO:0007597) | 2.70579563 |
| 129 | phosphatidylglycerol acyl-chain remodeling (GO:0036148) | 2.70138358 |
| 130 | cytolysis (GO:0019835) | 2.69844787 |
| 131 | killing of cells of other organism (GO:0031640) | 2.66377449 |
| 132 | disruption of cells of other organism (GO:0044364) | 2.66377449 |
| 133 | piRNA metabolic process (GO:0034587) | 2.63852465 |
| 134 | regulation of gamma-delta T cell activation (GO:0046643) | 2.63030816 |
| 135 | cytidine metabolic process (GO:0046087) | 2.57000509 |
| 136 | cytidine catabolic process (GO:0006216) | 2.57000509 |
| 137 | cytidine deamination (GO:0009972) | 2.57000509 |
| 138 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.55071638 |
| 139 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 2.53872346 |
| 140 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 2.53872346 |
| 141 | cellular response to interleukin-15 (GO:0071350) | 2.52804663 |
| 142 | detection of light stimulus involved in sensory perception (GO:0050962) | 2.51900717 |
| 143 | detection of light stimulus involved in visual perception (GO:0050908) | 2.51900717 |
| 144 | regulation of humoral immune response (GO:0002920) | 2.51524427 |
| 145 | drug transport (GO:0015893) | 2.51034818 |
| 146 | oxygen transport (GO:0015671) | 2.50658337 |
| 147 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.50014552 |
| 148 | thymic T cell selection (GO:0045061) | 2.48991117 |
| 149 | response to interleukin-15 (GO:0070672) | 2.48957467 |
| 150 | serine family amino acid metabolic process (GO:0009069) | 2.48573590 |
| 151 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.47270522 |
| 152 | response to mercury ion (GO:0046689) | 2.45583630 |
| 153 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.44782423 |
| 154 | DNA deamination (GO:0045006) | 2.44772692 |
| 155 | actin-myosin filament sliding (GO:0033275) | 2.44364684 |
| 156 | muscle filament sliding (GO:0030049) | 2.44364684 |
| 157 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.43509062 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 8.05419591 |
| 2 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 5.84319183 |
| 3 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 4.91227062 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 4.67901545 |
| 5 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.67734258 |
| 6 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 4.59446066 |
| 7 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.02896387 |
| 8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.45453652 |
| 9 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.87359712 |
| 10 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.85225318 |
| 11 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.23259161 |
| 12 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.18004806 |
| 13 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.13931114 |
| 14 | BCL6_27268052_Chip-Seq_Bcells_Human | 2.11036070 |
| 15 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 2.06700238 |
| 16 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.96692656 |
| 17 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.95100895 |
| 18 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.93572753 |
| 19 | * P68_20966046_ChIP-Seq_HELA_Human | 1.89807608 |
| 20 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.87812141 |
| 21 | * VDR_21846776_ChIP-Seq_THP-1_Human | 1.81983938 |
| 22 | OCT4_20526341_ChIP-Seq_ESCs_Human | 1.77306689 |
| 23 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.72590855 |
| 24 | * E2F1_20622854_ChIP-Seq_HELA_Human | 1.68151794 |
| 25 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.68127675 |
| 26 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.67104134 |
| 27 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.64990064 |
| 28 | * ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.64086698 |
| 29 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.62950834 |
| 30 | SA1_27219007_Chip-Seq_Bcells_Human | 1.62609179 |
| 31 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.61214188 |
| 32 | P300_27268052_Chip-Seq_Bcells_Human | 1.56195773 |
| 33 | ERA_21632823_ChIP-Seq_H3396_Human | 1.55917020 |
| 34 | * PHF8_20622854_ChIP-Seq_HELA_Human | 1.54735217 |
| 35 | * TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.54696144 |
| 36 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.54198996 |
| 37 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.53466346 |
| 38 | MAF_26560356_Chip-Seq_TH2_Human | 1.50253253 |
| 39 | RAC3_21632823_ChIP-Seq_H3396_Human | 1.49945698 |
| 40 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.49538885 |
| 41 | MAF_26560356_Chip-Seq_TH1_Human | 1.47650007 |
| 42 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.47604661 |
| 43 | * GATA1_19941826_ChIP-Seq_K562_Human | 1.45618702 |
| 44 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.45535014 |
| 45 | * TAF2_19829295_ChIP-Seq_ESCs_Human | 1.45464761 |
| 46 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.43773746 |
| 47 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.42578480 |
| 48 | * OCT4_19829295_ChIP-Seq_ESCs_Human | 1.37849412 |
| 49 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.37197148 |
| 50 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.34117811 |
| 51 | NANOG_20526341_ChIP-Seq_ESCs_Human | 1.33467047 |
| 52 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.33236593 |
| 53 | UTX_26944678_Chip-Seq_JUKART_Human | 1.32564663 |
| 54 | SPI1_20517297_ChIP-Seq_HL60_Human | 1.31908869 |
| 55 | GATA3_26560356_Chip-Seq_TH2_Human | 1.31713678 |
| 56 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.31559952 |
| 57 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.29221891 |
| 58 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.28639982 |
| 59 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.28628288 |
| 60 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.26934017 |
| 61 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.24133006 |
| 62 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 1.23928973 |
| 63 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.23692742 |
| 64 | * RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 1.22841167 |
| 65 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.21848705 |
| 66 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.21380014 |
| 67 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.21204699 |
| 68 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.20203429 |
| 69 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.19479766 |
| 70 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.18745060 |
| 71 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.18232837 |
| 72 | MYC_19829295_ChIP-Seq_ESCs_Human | 1.17979505 |
| 73 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.17868600 |
| 74 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 1.17720071 |
| 75 | NCOR_22424771_ChIP-Seq_293T_Human | 1.17256555 |
| 76 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.16953786 |
| 77 | P53_21459846_ChIP-Seq_SAOS-2_Human | 1.16922590 |
| 78 | CTCF_20526341_ChIP-Seq_ESCs_Human | 1.16836226 |
| 79 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.15152718 |
| 80 | * SOX2_21211035_ChIP-Seq_LN229_Human | 1.14678741 |
| 81 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.14213986 |
| 82 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.14157675 |
| 83 | MYB_26560356_Chip-Seq_TH2_Human | 1.13935255 |
| 84 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.13513595 |
| 85 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.13078743 |
| 86 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.12115246 |
| 87 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.11296451 |
| 88 | P63_20808887_ChIP-Seq_KERATINOCYTES_Human | 1.10123298 |
| 89 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.08714390 |
| 90 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.08554471 |
| 91 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.08414479 |
| 92 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.07639757 |
| 93 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.07516768 |
| 94 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.07286007 |
| 95 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.06771994 |
| 96 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.06435990 |
| 97 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.05984024 |
| 98 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.05774037 |
| 99 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.03847830 |
| 100 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 1.03564570 |
| 101 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.02596156 |
| 102 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.02281859 |
| 103 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.02215306 |
| 104 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.02113852 |
| 105 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.01763415 |
| 106 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.01623724 |
| 107 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.01582410 |
| 108 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.00071312 |
| 109 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.99630374 |
| 110 | GATA1_22025678_ChIP-Seq_K562_Human | 0.99278404 |
| 111 | CTCF_21964334_Chip-Seq_Bcells_Human | 0.99140598 |
| 112 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.99034985 |
| 113 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 0.98715072 |
| 114 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 0.98715072 |
| 115 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.97891834 |
| 116 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.97255937 |
| 117 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 0.96633206 |
| 118 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 0.96536550 |
| 119 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.96196424 |
| 120 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.95225040 |
| 121 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 0.93405393 |
| 122 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.93069066 |
| 123 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 0.92837761 |
| 124 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 0.92225392 |
| 125 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.91001266 |
| 126 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.87983039 |
| 127 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 0.87385695 |
| 128 | * ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.84192778 |
| 129 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.83985352 |
| 130 | * PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.83869135 |
| 131 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.83522032 |
| 132 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.83522032 |
| 133 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.83350733 |
| 134 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 0.82270503 |
| 135 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.82055436 |
| 136 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.81501839 |
| 137 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.80564448 |
| 138 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.79780374 |
| 139 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 0.79738318 |
| 140 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.79584339 |
| 141 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.79138245 |
| 142 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.78903662 |
| 143 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.78606644 |
| 144 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.78180595 |
| 145 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.76313089 |
| 146 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.75724553 |
| 147 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.75588581 |
| 148 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.75406144 |
| 149 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.75091200 |
| 150 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.74411342 |
| 151 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.74264866 |
| 152 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.74264866 |
| 153 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.72758797 |
| 154 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.70742967 |
| 155 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.70709682 |
| 156 | P300_19829295_ChIP-Seq_ESCs_Human | 0.70226641 |
| 157 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.69413747 |
| 158 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.68679577 |
| 159 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.68617257 |
| 160 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.68517453 |
| 161 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.67794564 |
| 162 | * TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.67514240 |
| 163 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.67471769 |
| 164 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.67190982 |
| 165 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.67071873 |
| 166 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.66266520 |
| 167 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 0.65811447 |
| 168 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.65748848 |
| 169 | CBP_21632823_ChIP-Seq_H3396_Human | 0.65106349 |
| 170 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.64500440 |
| 171 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.64272297 |
| 172 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.64242022 |
| 173 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.64237960 |
| 174 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.63811396 |
| 175 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.62415503 |
| 176 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.61784933 |
| 177 | REST_21632747_ChIP-Seq_MESCs_Mouse | 0.61616025 |
| 178 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.60481728 |
| 179 | * ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.60013860 |
| 180 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 0.59430730 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 7.09274246 |
| 2 | MP0005360_urolithiasis | 6.45589241 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 5.78942770 |
| 4 | MP0005365_abnormal_bile_salt | 5.49888511 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.35812272 |
| 6 | MP0003252_abnormal_bile_duct | 3.58793873 |
| 7 | MP0010329_abnormal_lipoprotein_level | 3.18858160 |
| 8 | MP0003195_calcinosis | 2.99997142 |
| 9 | MP0004145_abnormal_muscle_electrophysio | 2.99437440 |
| 10 | MP0003806_abnormal_nucleotide_metabolis | 2.99091064 |
| 11 | MP0005332_abnormal_amino_acid | 2.87003366 |
| 12 | MP0002837_dystrophic_cardiac_calcinosis | 2.72217391 |
| 13 | MP0005670_abnormal_white_adipose | 2.67551692 |
| 14 | MP0005083_abnormal_biliary_tract | 2.43793348 |
| 15 | MP0001666_abnormal_nutrient_absorption | 2.18403989 |
| 16 | MP0002118_abnormal_lipid_homeostasis | 2.18140217 |
| 17 | MP0004019_abnormal_vitamin_homeostasis | 2.17222155 |
| 18 | MP0009840_abnormal_foam_cell | 2.14938098 |
| 19 | MP0001986_abnormal_taste_sensitivity | 1.93884006 |
| 20 | MP0002138_abnormal_hepatobiliary_system | 1.92249036 |
| 21 | MP0003191_abnormal_cellular_cholesterol | 1.84904094 |
| 22 | MP0005451_abnormal_body_composition | 1.84373892 |
| 23 | MP0002653_abnormal_ependyma_morphology | 1.83422286 |
| 24 | MP0000609_abnormal_liver_physiology | 1.81038968 |
| 25 | MP0004130_abnormal_muscle_cell | 1.77758122 |
| 26 | MP0003646_muscle_fatigue | 1.75065280 |
| 27 | MP0003868_abnormal_feces_composition | 1.66754190 |
| 28 | MP0002132_abnormal_respiratory_system | 1.64878317 |
| 29 | MP0005319_abnormal_enzyme/_coenzyme | 1.64005451 |
| 30 | MP0004782_abnormal_surfactant_physiolog | 1.63549625 |
| 31 | MP0005666_abnormal_adipose_tissue | 1.61366354 |
| 32 | MP0001968_abnormal_touch/_nociception | 1.55881681 |
| 33 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.53925868 |
| 34 | MP0002822_catalepsy | 1.52170101 |
| 35 | MP0001873_stomach_inflammation | 1.46804561 |
| 36 | MP0001764_abnormal_homeostasis | 1.45019361 |
| 37 | MP0005671_abnormal_response_to | 1.42114362 |
| 38 | MP0002971_abnormal_brown_adipose | 1.38318753 |
| 39 | MP0005535_abnormal_body_temperature | 1.36328043 |
| 40 | MP0001800_abnormal_humoral_immune | 1.36284733 |
| 41 | MP0006036_abnormal_mitochondrial_physio | 1.34900952 |
| 42 | MP0003763_abnormal_thymus_physiology | 1.32819931 |
| 43 | MP0009643_abnormal_urine_homeostasis | 1.31160260 |
| 44 | MP0004043_abnormal_pH_regulation | 1.26800128 |
| 45 | MP0002876_abnormal_thyroid_physiology | 1.24828278 |
| 46 | MP0002106_abnormal_muscle_physiology | 1.23844451 |
| 47 | MP0009333_abnormal_splenocyte_physiolog | 1.23105500 |
| 48 | MP0003436_decreased_susceptibility_to | 1.22751926 |
| 49 | MP0001502_abnormal_circadian_rhythm | 1.16958624 |
| 50 | MP0005330_cardiomyopathy | 1.14525986 |
| 51 | MP0005645_abnormal_hypothalamus_physiol | 1.11780641 |
| 52 | MP0005000_abnormal_immune_tolerance | 1.11518654 |
| 53 | MP0004215_abnormal_myocardial_fiber | 1.11239120 |
| 54 | MP0002078_abnormal_glucose_homeostasis | 1.11102427 |
| 55 | MP0002736_abnormal_nociception_after | 1.08613947 |
| 56 | MP0002723_abnormal_immune_serum | 1.05678485 |
| 57 | MP0003303_peritoneal_inflammation | 1.04391737 |
| 58 | MP0005334_abnormal_fat_pad | 1.04229297 |
| 59 | MP0005647_abnormal_sex_gland | 1.03936950 |
| 60 | MP0003879_abnormal_hair_cell | 1.03132941 |
| 61 | MP0000685_abnormal_immune_system | 1.01177913 |
| 62 | MP0005025_abnormal_response_to | 1.00963262 |
| 63 | MP0000751_myopathy | 1.00908711 |
| 64 | MP0009697_abnormal_copulation | 0.99653392 |
| 65 | MP0006082_CNS_inflammation | 0.96410331 |
| 66 | MP0002254_reproductive_system_inflammat | 0.96091501 |
| 67 | MP0005369_muscle_phenotype | 0.95634027 |
| 68 | MP0003011_delayed_dark_adaptation | 0.95200309 |
| 69 | MP0009745_abnormal_behavioral_response | 0.94879195 |
| 70 | MP0003656_abnormal_erythrocyte_physiolo | 0.94253749 |
| 71 | MP0005636_abnormal_mineral_homeostasis | 0.93916210 |
| 72 | MP0001501_abnormal_sleep_pattern | 0.93567838 |
| 73 | MP0005423_abnormal_somatic_nervous | 0.93035644 |
| 74 | MP0009785_altered_susceptibility_to | 0.91951362 |
| 75 | MP0009764_decreased_sensitivity_to | 0.91939929 |
| 76 | MP0008995_early_reproductive_senescence | 0.91037667 |
| 77 | MP0009278_abnormal_bone_marrow | 0.91000622 |
| 78 | MP0002420_abnormal_adaptive_immunity | 0.90157737 |
| 79 | MP0005397_hematopoietic_system_phenotyp | 0.89335430 |
| 80 | MP0001545_abnormal_hematopoietic_system | 0.89335430 |
| 81 | MP0004185_abnormal_adipocyte_glucose | 0.89253071 |
| 82 | MP0001819_abnormal_immune_cell | 0.87281595 |
| 83 | MP0005375_adipose_tissue_phenotype | 0.85347201 |
| 84 | MP0004036_abnormal_muscle_relaxation | 0.84108027 |
| 85 | MP0001790_abnormal_immune_system | 0.83209757 |
| 86 | MP0005387_immune_system_phenotype | 0.83209757 |
| 87 | MP0002735_abnormal_chemical_nociception | 0.82980136 |
| 88 | MP0000689_abnormal_spleen_morphology | 0.82216165 |
| 89 | MP0009642_abnormal_blood_homeostasis | 0.82037798 |
| 90 | MP0005448_abnormal_energy_balance | 0.81491492 |
| 91 | MP0003186_abnormal_redox_activity | 0.80533052 |
| 92 | MP0005377_hearing/vestibular/ear_phenot | 0.79730992 |
| 93 | MP0003878_abnormal_ear_physiology | 0.79730992 |
| 94 | MP0000681_abnormal_thyroid_gland | 0.78468062 |
| 95 | MP0002398_abnormal_bone_marrow | 0.78276937 |
| 96 | MP0003690_abnormal_glial_cell | 0.78015767 |
| 97 | MP0003183_abnormal_peptide_metabolism | 0.77552862 |
| 98 | MP0008877_abnormal_DNA_methylation | 0.77460466 |
| 99 | MP0004142_abnormal_muscle_tone | 0.77438721 |
| 100 | MP0003137_abnormal_impulse_conducting | 0.77016541 |
| 101 | MP0000372_irregular_coat_pigmentation | 0.76511607 |
| 102 | MP0000230_abnormal_systemic_arterial | 0.75748003 |
| 103 | MP0000759_abnormal_skeletal_muscle | 0.75012682 |
| 104 | MP0000716_abnormal_immune_system | 0.74258785 |
| 105 | MP0002064_seizures | 0.73795181 |
| 106 | MP0002452_abnormal_antigen_presenting | 0.73130681 |
| 107 | MP0006276_abnormal_autonomic_nervous | 0.73045158 |
| 108 | MP0005620_abnormal_muscle_contractility | 0.72768847 |
| 109 | MP0001661_extended_life_span | 0.72316232 |
| 110 | MP0009763_increased_sensitivity_to | 0.71743215 |
| 111 | MP0000749_muscle_degeneration | 0.70694465 |
| 112 | MP0000598_abnormal_liver_morphology | 0.70658753 |
| 113 | MP0006138_congestive_heart_failure | 0.69970415 |
| 114 | MP0001756_abnormal_urination | 0.67236381 |
| 115 | MP0003953_abnormal_hormone_level | 0.66775522 |
| 116 | MP0006035_abnormal_mitochondrial_morpho | 0.66725075 |
| 117 | MP0004085_abnormal_heartbeat | 0.66557014 |
| 118 | MP0002972_abnormal_cardiac_muscle | 0.65243600 |
| 119 | MP0008775_abnormal_heart_ventricle | 0.65181520 |
| 120 | MP0001765_abnormal_ion_homeostasis | 0.64886895 |
| 121 | MP0000604_amyloidosis | 0.64594674 |
| 122 | MP0005376_homeostasis/metabolism_phenot | 0.64437406 |
| 123 | MP0008874_decreased_physiological_sensi | 0.63458038 |
| 124 | MP0010368_abnormal_lymphatic_system | 0.61996465 |
| 125 | MP0002269_muscular_atrophy | 0.61727564 |
| 126 | MP0005084_abnormal_gallbladder_morpholo | 0.61635453 |
| 127 | MP0005266_abnormal_metabolism | 0.60515700 |
| 128 | MP0009115_abnormal_fat_cell | 0.59354963 |
| 129 | MP0000566_synostosis | 0.59193674 |
| 130 | MP0008872_abnormal_physiological_respon | 0.59098075 |
| 131 | MP0005385_cardiovascular_system_phenoty | 0.59073148 |
| 132 | MP0001544_abnormal_cardiovascular_syste | 0.59073148 |
| 133 | MP0005646_abnormal_pituitary_gland | 0.57517910 |
| 134 | MP0004084_abnormal_cardiac_muscle | 0.56571196 |
| 135 | MP0004087_abnormal_muscle_fiber | 0.55534987 |
| 136 | MP0008469_abnormal_protein_level | 0.54632473 |
| 137 | MP0003329_amyloid_beta_deposits | 0.53666595 |
| 138 | MP0002332_abnormal_exercise_endurance | 0.52958941 |
| 139 | MP0004147_increased_porphyrin_level | 0.52507626 |
| 140 | MP0009780_abnormal_chondrocyte_physiolo | 0.52271355 |
| 141 | MP0004381_abnormal_hair_follicle | 0.50583600 |
| 142 | MP0005595_abnormal_vascular_smooth | 0.49180830 |
| 143 | MP0008961_abnormal_basal_metabolism | 0.48544653 |
| 144 | MP0000579_abnormal_nail_morphology | 0.48425028 |
| 145 | MP0002970_abnormal_white_adipose | 0.47753953 |
| 146 | MP0002136_abnormal_kidney_physiology | 0.45004486 |
| 147 | MP0005551_abnormal_eye_electrophysiolog | 0.44561584 |
| 148 | MP0009765_abnormal_xenobiotic_induced | 0.44257286 |
| 149 | MP0005452_abnormal_adipose_tissue | 0.43840929 |
| 150 | MP0002928_abnormal_bile_duct | 0.42396025 |
| 151 | MP0000747_muscle_weakness | 0.42106604 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Intrahepatic cholestasis (HP:0001406) | 5.77565898 |
| 2 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 5.76868941 |
| 3 | Deep venous thrombosis (HP:0002625) | 5.36100148 |
| 4 | Prolonged partial thromboplastin time (HP:0003645) | 5.31589203 |
| 5 | Xanthomatosis (HP:0000991) | 4.92097764 |
| 6 | Hyperglycinuria (HP:0003108) | 4.91959276 |
| 7 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 4.81349957 |
| 8 | Ketosis (HP:0001946) | 4.77015957 |
| 9 | Hyperlipoproteinemia (HP:0010980) | 4.63451968 |
| 10 | Hyperammonemia (HP:0001987) | 4.61224301 |
| 11 | Hypoglycemic coma (HP:0001325) | 4.53692246 |
| 12 | Abnormality of glycine metabolism (HP:0010895) | 4.52458886 |
| 13 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.52458886 |
| 14 | Hyperglycinemia (HP:0002154) | 4.41617403 |
| 15 | Abnormality of fatty-acid metabolism (HP:0004359) | 4.16879298 |
| 16 | Hypobetalipoproteinemia (HP:0003563) | 4.11070427 |
| 17 | Ketoacidosis (HP:0001993) | 4.10503522 |
| 18 | Complement deficiency (HP:0004431) | 4.04790853 |
| 19 | Muscle fiber inclusion bodies (HP:0100299) | 4.00117814 |
| 20 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.99645991 |
| 21 | Joint hemorrhage (HP:0005261) | 3.83263972 |
| 22 | Nemaline bodies (HP:0003798) | 3.80398100 |
| 23 | Hypoalphalipoproteinemia (HP:0003233) | 3.77533302 |
| 24 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 3.74160301 |
| 25 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.66573470 |
| 26 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 3.66455776 |
| 27 | Dicarboxylic aciduria (HP:0003215) | 3.66455776 |
| 28 | Epidermoid cyst (HP:0200040) | 3.63656919 |
| 29 | Hypolipoproteinemia (HP:0010981) | 3.62377007 |
| 30 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.59335499 |
| 31 | Hypochromic anemia (HP:0001931) | 3.55728926 |
| 32 | Abnormality of methionine metabolism (HP:0010901) | 3.40589460 |
| 33 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.38736562 |
| 34 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.36062669 |
| 35 | Metabolic acidosis (HP:0001942) | 3.21347511 |
| 36 | Conjugated hyperbilirubinemia (HP:0002908) | 3.17139638 |
| 37 | Abnormality of serum amino acid levels (HP:0003112) | 3.10652461 |
| 38 | Abnormality of the common coagulation pathway (HP:0010990) | 3.10104148 |
| 39 | Generalized aminoaciduria (HP:0002909) | 3.07061671 |
| 40 | Fat malabsorption (HP:0002630) | 3.03057398 |
| 41 | Renal cortical cysts (HP:0000803) | 3.01296903 |
| 42 | Cerebral edema (HP:0002181) | 2.96918975 |
| 43 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.94778079 |
| 44 | Lethargy (HP:0001254) | 2.93048282 |
| 45 | Gastrointestinal infarctions (HP:0005244) | 2.91177355 |
| 46 | Congenital stationary night blindness (HP:0007642) | 2.90166659 |
| 47 | Delayed CNS myelination (HP:0002188) | 2.85337166 |
| 48 | Myoglobinuria (HP:0002913) | 2.82619313 |
| 49 | Gout (HP:0001997) | 2.79114882 |
| 50 | Abnormality of eosinophils (HP:0001879) | 2.77944108 |
| 51 | Hyperbilirubinemia (HP:0002904) | 2.77560538 |
| 52 | Abnormality of purine metabolism (HP:0004352) | 2.76599626 |
| 53 | Abnormality of nucleobase metabolism (HP:0010932) | 2.75219593 |
| 54 | Myopathic facies (HP:0002058) | 2.72999917 |
| 55 | Proximal tubulopathy (HP:0000114) | 2.72789325 |
| 56 | Hypercholesterolemia (HP:0003124) | 2.72468470 |
| 57 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.72459527 |
| 58 | Abnormality of complement system (HP:0005339) | 2.71211236 |
| 59 | Poikilocytosis (HP:0004447) | 2.70344055 |
| 60 | Hemorrhage of the eye (HP:0011885) | 2.69931812 |
| 61 | Hypoglycemic seizures (HP:0002173) | 2.69605288 |
| 62 | Type 1 muscle fiber predominance (HP:0003803) | 2.68952975 |
| 63 | Stomatitis (HP:0010280) | 2.68461036 |
| 64 | Neck muscle weakness (HP:0000467) | 2.68098328 |
| 65 | Abnormality of proline metabolism (HP:0010907) | 2.67334645 |
| 66 | Hydroxyprolinuria (HP:0003080) | 2.67334645 |
| 67 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.62735185 |
| 68 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.62524572 |
| 69 | Abnormality of the intrinsic pathway (HP:0010989) | 2.62002157 |
| 70 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.60938466 |
| 71 | Vascular calcification (HP:0004934) | 2.55253509 |
| 72 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.51400506 |
| 73 | Vomiting (HP:0002013) | 2.50403016 |
| 74 | Increased IgM level (HP:0003496) | 2.45379612 |
| 75 | Enlarged kidneys (HP:0000105) | 2.40848595 |
| 76 | Skin nodule (HP:0200036) | 2.36522020 |
| 77 | Calf muscle hypertrophy (HP:0008981) | 2.33552977 |
| 78 | Exercise-induced myalgia (HP:0003738) | 2.31658329 |
| 79 | Hyperventilation (HP:0002883) | 2.30597023 |
| 80 | Myocardial infarction (HP:0001658) | 2.28865985 |
| 81 | Abnormal gallbladder morphology (HP:0012437) | 2.27035887 |
| 82 | Cholelithiasis (HP:0001081) | 2.26740841 |
| 83 | Hypochromic microcytic anemia (HP:0004840) | 2.26373480 |
| 84 | Steatorrhea (HP:0002570) | 2.24640375 |
| 85 | Hyperuricemia (HP:0002149) | 2.22294873 |
| 86 | Increased purine levels (HP:0004368) | 2.22294873 |
| 87 | Sensorimotor neuropathy (HP:0007141) | 2.22284858 |
| 88 | Cardiovascular calcification (HP:0011915) | 2.21407205 |
| 89 | Abnormality of urine glucose concentration (HP:0011016) | 2.20798582 |
| 90 | Glycosuria (HP:0003076) | 2.20798582 |
| 91 | Abnormality of T cell physiology (HP:0011840) | 2.19254970 |
| 92 | Reticulocytosis (HP:0001923) | 2.16748309 |
| 93 | Hepatic necrosis (HP:0002605) | 2.16531238 |
| 94 | Stomach cancer (HP:0012126) | 2.15294174 |
| 95 | Spontaneous abortion (HP:0005268) | 2.15237550 |
| 96 | Neonatal onset (HP:0003623) | 2.14361736 |
| 97 | Distal arthrogryposis (HP:0005684) | 2.12141789 |
| 98 | Anorexia (HP:0002039) | 2.12123966 |
| 99 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.09143652 |
| 100 | Increased muscle lipid content (HP:0009058) | 2.08784704 |
| 101 | Hepatocellular carcinoma (HP:0001402) | 2.08678953 |
| 102 | Encephalitis (HP:0002383) | 2.08458093 |
| 103 | Rhabdomyolysis (HP:0003201) | 2.08222644 |
| 104 | Pancreatitis (HP:0001733) | 2.08039784 |
| 105 | Ulnar deviation of the wrist (HP:0003049) | 2.07954640 |
| 106 | Sudden death (HP:0001699) | 2.06024378 |
| 107 | Attenuation of retinal blood vessels (HP:0007843) | 2.05606310 |
| 108 | Symptomatic seizures (HP:0011145) | 2.05092461 |
| 109 | Hyperglycemia (HP:0003074) | 2.04347885 |
| 110 | Panhypogammaglobulinemia (HP:0003139) | 2.03784074 |
| 111 | Late onset (HP:0003584) | 2.02164818 |
| 112 | Increased serum ferritin (HP:0003281) | 2.01761591 |
| 113 | Acute encephalopathy (HP:0006846) | 2.01747213 |
| 114 | Methylmalonic aciduria (HP:0012120) | 2.01499943 |
| 115 | Alkalosis (HP:0001948) | 2.01149459 |
| 116 | Muscle fiber splitting (HP:0003555) | 2.00712082 |
| 117 | Chronic hepatic failure (HP:0100626) | 2.00675539 |
| 118 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.98515124 |
| 119 | Hypophosphatemic rickets (HP:0004912) | 1.98200218 |
| 120 | Abnormality of iron homeostasis (HP:0011031) | 1.98039342 |
| 121 | Eosinophilia (HP:0001880) | 1.97821137 |
| 122 | Cheilitis (HP:0100825) | 1.97216562 |
| 123 | Rickets (HP:0002748) | 1.96952679 |
| 124 | Myositis (HP:0100614) | 1.96748259 |
| 125 | Meningitis (HP:0001287) | 1.96743440 |
| 126 | Round ear (HP:0100830) | 1.96022964 |
| 127 | Methylmalonic acidemia (HP:0002912) | 1.95335843 |
| 128 | Cerebral palsy (HP:0100021) | 1.95147516 |
| 129 | Exercise-induced muscle cramps (HP:0003710) | 1.95088470 |
| 130 | EMG: myopathic abnormalities (HP:0003458) | 1.92212197 |
| 131 | Confusion (HP:0001289) | 1.91895375 |
| 132 | Nausea (HP:0002018) | 1.91796065 |
| 133 | Abnormality of the fingertips (HP:0001211) | 1.91033479 |
| 134 | Granulocytopenia (HP:0001913) | 1.90515929 |
| 135 | Status epilepticus (HP:0002133) | 1.89719625 |
| 136 | Irritability (HP:0000737) | 1.89528711 |
| 137 | Hyperthyroidism (HP:0000836) | 1.89226855 |
| 138 | Systemic lupus erythematosus (HP:0002725) | 1.88834651 |
| 139 | Asymmetric septal hypertrophy (HP:0001670) | 1.87603173 |
| 140 | Hyporeflexia of lower limbs (HP:0002600) | 1.86949778 |
| 141 | Atrioventricular block (HP:0001678) | 1.85813384 |
| 142 | Brushfield spots (HP:0001088) | 1.84914330 |
| 143 | Muscle stiffness (HP:0003552) | 1.84293135 |
| 144 | Optic neuritis (HP:0100653) | 1.84242409 |
| 145 | Retrobulbar optic neuritis (HP:0100654) | 1.84242409 |
| 146 | Abnormality of vitamin metabolism (HP:0100508) | 1.84064019 |
| 147 | Abnormality of the gallbladder (HP:0005264) | 1.83929963 |
| 148 | Mesangial abnormality (HP:0001966) | 1.83573776 |
| 149 | Mitral stenosis (HP:0001718) | 1.83178796 |
| 150 | Long clavicles (HP:0000890) | 1.81945263 |
| 151 | Abnormal gallbladder physiology (HP:0012438) | 1.81613366 |
| 152 | Cholecystitis (HP:0001082) | 1.81613366 |
| 153 | Recurrent fungal infections (HP:0002841) | 1.80280287 |
| 154 | Decreased central vision (HP:0007663) | 1.78106921 |
| 155 | EMG: neuropathic changes (HP:0003445) | 1.77881107 |
| 156 | Heart block (HP:0012722) | 1.77040810 |
| 157 | Prolonged bleeding time (HP:0003010) | 1.72478573 |
| 158 | Keratoconjunctivitis (HP:0001096) | 1.71545218 |
| 159 | Abnormality of T cells (HP:0002843) | 1.69348160 |
| 160 | Dyskinesia (HP:0100660) | 1.69119121 |
| 161 | Conical tooth (HP:0000698) | 1.68930504 |
| 162 | Vasculitis (HP:0002633) | 1.67826204 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 5.38035833 |
| 2 | INSRR | 3.95270176 |
| 3 | SIK1 | 3.35304547 |
| 4 | MAP4K1 | 2.99541532 |
| 5 | FGFR4 | 2.53959714 |
| 6 | PINK1 | 2.26309918 |
| 7 | TNK2 | 2.23466661 |
| 8 | RIPK4 | 2.05620582 |
| 9 | TXK | 2.01459118 |
| 10 | TLK1 | 1.88561624 |
| 11 | EPHA4 | 1.87327483 |
| 12 | TAOK2 | 1.86777158 |
| 13 | MAP2K4 | 1.85870486 |
| 14 | ERN1 | 1.77173083 |
| 15 | ITK | 1.71476458 |
| 16 | PDK3 | 1.67286991 |
| 17 | PDK4 | 1.67286991 |
| 18 | PHKG2 | 1.65864957 |
| 19 | PHKG1 | 1.65864957 |
| 20 | TAOK3 | 1.61468041 |
| 21 | WNK4 | 1.59291881 |
| 22 | GRK6 | 1.53660495 |
| 23 | OBSCN | 1.50119361 |
| 24 | ERBB4 | 1.48670466 |
| 25 | PRKAA2 | 1.46699522 |
| 26 | TIE1 | 1.44644096 |
| 27 | SYK | 1.42243375 |
| 28 | MAP3K7 | 1.40552859 |
| 29 | MST1R | 1.38618416 |
| 30 | MAPK13 | 1.35485713 |
| 31 | CAMK1D | 1.33405828 |
| 32 | DAPK2 | 1.30197559 |
| 33 | PIK3CG | 1.30129045 |
| 34 | CAMK1G | 1.27925918 |
| 35 | PRPF4B | 1.26461507 |
| 36 | CASK | 1.26428767 |
| 37 | GRK7 | 1.25118977 |
| 38 | PKN1 | 1.23928955 |
| 39 | MAPK11 | 1.20355253 |
| 40 | STK38L | 1.19321763 |
| 41 | MAPK15 | 1.19092282 |
| 42 | BTK | 1.18437497 |
| 43 | FES | 1.16908544 |
| 44 | MAPK12 | 1.16600295 |
| 45 | MAPKAPK3 | 1.15683970 |
| 46 | ZAP70 | 1.13245674 |
| 47 | MYLK | 1.13222922 |
| 48 | MAP4K2 | 1.12793931 |
| 49 | MAP2K2 | 1.12219283 |
| 50 | SIK2 | 1.11763248 |
| 51 | PDK2 | 1.11734824 |
| 52 | BLK | 1.11310214 |
| 53 | IKBKB | 1.11029788 |
| 54 | TYK2 | 1.09837533 |
| 55 | MAP3K11 | 1.08187860 |
| 56 | SGK3 | 1.07952738 |
| 57 | PIK3CA | 1.07410815 |
| 58 | SGK2 | 1.06146686 |
| 59 | MUSK | 1.04557450 |
| 60 | OXSR1 | 1.04467348 |
| 61 | RIPK1 | 1.04366744 |
| 62 | LATS1 | 1.03136827 |
| 63 | WNK3 | 1.00703780 |
| 64 | ADRBK2 | 1.00619332 |
| 65 | IRAK4 | 0.98536494 |
| 66 | SGK494 | 0.98102789 |
| 67 | SGK223 | 0.98102789 |
| 68 | TTN | 0.96405706 |
| 69 | TNIK | 0.96184650 |
| 70 | PDPK1 | 0.96087715 |
| 71 | PRKAA1 | 0.96064882 |
| 72 | IRAK3 | 0.94767438 |
| 73 | CAMKK1 | 0.94499347 |
| 74 | LCK | 0.94298475 |
| 75 | MARK3 | 0.92330480 |
| 76 | LMTK2 | 0.91683519 |
| 77 | TRIB3 | 0.91535400 |
| 78 | STK38 | 0.89834290 |
| 79 | PTK2B | 0.86919296 |
| 80 | FGFR2 | 0.86462171 |
| 81 | SIK3 | 0.86182371 |
| 82 | HCK | 0.82930953 |
| 83 | NTRK3 | 0.80652510 |
| 84 | MARK1 | 0.78689927 |
| 85 | HIPK2 | 0.77822197 |
| 86 | CAMK2G | 0.77067073 |
| 87 | PRKACG | 0.76863008 |
| 88 | MAPK7 | 0.76714942 |
| 89 | MAP3K4 | 0.74971562 |
| 90 | JAK1 | 0.73923571 |
| 91 | JAK3 | 0.70856991 |
| 92 | CAMK2A | 0.69823289 |
| 93 | DMPK | 0.68948450 |
| 94 | GRK1 | 0.68179051 |
| 95 | PRKCI | 0.68108416 |
| 96 | MAP2K7 | 0.67575180 |
| 97 | PRKD1 | 0.67482809 |
| 98 | TESK2 | 0.66756699 |
| 99 | PIM1 | 0.66660755 |
| 100 | CAMK4 | 0.66361485 |
| 101 | EPHB1 | 0.65708361 |
| 102 | PRKCZ | 0.65442904 |
| 103 | MAP3K14 | 0.62576049 |
| 104 | PDK1 | 0.62091973 |
| 105 | ABL2 | 0.61943098 |
| 106 | CAMK1 | 0.61670981 |
| 107 | MAP2K1 | 0.61485023 |
| 108 | STK39 | 0.61076163 |
| 109 | BMPR2 | 0.60971730 |
| 110 | CAMK2D | 0.60437801 |
| 111 | PAK3 | 0.59519904 |
| 112 | LYN | 0.58460913 |
| 113 | PKN2 | 0.58075003 |
| 114 | SGK1 | 0.57081729 |
| 115 | TEC | 0.56459866 |
| 116 | PRKACA | 0.56077994 |
| 117 | TBK1 | 0.56019037 |
| 118 | JAK2 | 0.56012248 |
| 119 | MAP3K6 | 0.55883009 |
| 120 | PRKCH | 0.55422968 |
| 121 | CCNB1 | 0.55104740 |
| 122 | MAP2K3 | 0.54127761 |
| 123 | PRKCQ | 0.53905633 |
| 124 | FLT3 | 0.52917925 |
| 125 | AKT3 | 0.52510079 |
| 126 | TGFBR2 | 0.50463866 |
| 127 | IRAK2 | 0.50138910 |
| 128 | MAPK4 | 0.48819831 |
| 129 | PRKCE | 0.48540744 |
| 130 | PRKCG | 0.48482106 |
| 131 | IKBKE | 0.47886802 |
| 132 | FRK | 0.47845480 |
| 133 | RPS6KA6 | 0.47468695 |
| 134 | ZAK | 0.46725259 |
| 135 | ERBB2 | 0.44542071 |
| 136 | MAP3K13 | 0.44313770 |
| 137 | CDK4 | 0.44206338 |
| 138 | MAPK3 | 0.43259424 |
| 139 | RPS6KA5 | 0.43173521 |
| 140 | MARK2 | 0.42862438 |
| 141 | WNK1 | 0.42829093 |
| 142 | CAMKK2 | 0.42223265 |
| 143 | PRKD2 | 0.41310911 |
| 144 | RPS6KB1 | 0.41006000 |
| 145 | CDK19 | 0.40147372 |
| 146 | CSNK1A1 | 0.38906741 |
| 147 | PRKCA | 0.38202845 |
| 148 | STK11 | 0.37916591 |
| 149 | MAP2K6 | 0.37555967 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.72330552 |
| 2 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 3.15464954 |
| 3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.08144695 |
| 4 | Fatty acid degradation_Homo sapiens_hsa00071 | 3.07966375 |
| 5 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.97631578 |
| 6 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.88694749 |
| 7 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.74537075 |
| 8 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.71817965 |
| 9 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.70184814 |
| 10 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.64582606 |
| 11 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.58759086 |
| 12 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.57402974 |
| 13 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.53920973 |
| 14 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.44674134 |
| 15 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.17038554 |
| 16 | Peroxisome_Homo sapiens_hsa04146 | 2.11098819 |
| 17 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.09967763 |
| 18 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.04657339 |
| 19 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.04358357 |
| 20 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.98775997 |
| 21 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.95686862 |
| 22 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.93244047 |
| 23 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.83483992 |
| 24 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.82415230 |
| 25 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.78282703 |
| 26 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.69020071 |
| 27 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.67918387 |
| 28 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.67359661 |
| 29 | Histidine metabolism_Homo sapiens_hsa00340 | 1.66446157 |
| 30 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.56158118 |
| 31 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.55183258 |
| 32 | Phototransduction_Homo sapiens_hsa04744 | 1.54589401 |
| 33 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.49600378 |
| 34 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.47863630 |
| 35 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.46921795 |
| 36 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.46272966 |
| 37 | Retinol metabolism_Homo sapiens_hsa00830 | 1.45392614 |
| 38 | Bile secretion_Homo sapiens_hsa04976 | 1.42737122 |
| 39 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.34955937 |
| 40 | Carbon metabolism_Homo sapiens_hsa01200 | 1.34481869 |
| 41 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.33210109 |
| 42 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.31312011 |
| 43 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.30578452 |
| 44 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.24875125 |
| 45 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.23858775 |
| 46 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.23854079 |
| 47 | ABC transporters_Homo sapiens_hsa02010 | 1.23263063 |
| 48 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.22553617 |
| 49 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.22018899 |
| 50 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.18485384 |
| 51 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.15845501 |
| 52 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.09425047 |
| 53 | Lysine degradation_Homo sapiens_hsa00310 | 1.08304308 |
| 54 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.02682459 |
| 55 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.02118011 |
| 56 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.99340778 |
| 57 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.98548074 |
| 58 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.95623721 |
| 59 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.93262688 |
| 60 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.92267292 |
| 61 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.91470324 |
| 62 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.91418745 |
| 63 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.91311472 |
| 64 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.89372476 |
| 65 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.89007965 |
| 66 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.81779117 |
| 67 | Allograft rejection_Homo sapiens_hsa05330 | 0.80481268 |
| 68 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.79551807 |
| 69 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.74777624 |
| 70 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.73630026 |
| 71 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.70337995 |
| 72 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.69678419 |
| 73 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.65581313 |
| 74 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.63470148 |
| 75 | Sulfur relay system_Homo sapiens_hsa04122 | 0.60241786 |
| 76 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.53813114 |
| 77 | Metabolic pathways_Homo sapiens_hsa01100 | 0.49781466 |
| 78 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.48728381 |
| 79 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.47968393 |
| 80 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.46319982 |
| 81 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.43669420 |
| 82 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.43475245 |
| 83 | Insulin resistance_Homo sapiens_hsa04931 | 0.40851003 |
| 84 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.40369527 |
| 85 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.39675657 |
| 86 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.36549317 |
| 87 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.34202813 |
| 88 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.34174205 |
| 89 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.33563982 |
| 90 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.32770934 |
| 91 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.30983991 |
| 92 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.27745647 |
| 93 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.27586021 |
| 94 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.25432699 |
| 95 | Olfactory transduction_Homo sapiens_hsa04740 | 0.25101499 |
| 96 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.24654576 |
| 97 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.22779188 |
| 98 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.22757931 |
| 99 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.22315249 |
| 100 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.21524773 |
| 101 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.21247113 |
| 102 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.21140348 |
| 103 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.20797395 |
| 104 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.20611723 |
| 105 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.17631035 |
| 106 | Galactose metabolism_Homo sapiens_hsa00052 | 0.17355236 |
| 107 | Alzheimers disease_Homo sapiens_hsa05010 | 0.14378451 |
| 108 | Prion diseases_Homo sapiens_hsa05020 | 0.11509874 |
| 109 | Parkinsons disease_Homo sapiens_hsa05012 | 0.11044907 |
| 110 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.10051348 |
| 111 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.09778413 |
| 112 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.08963793 |
| 113 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.08374397 |
| 114 | Nicotine addiction_Homo sapiens_hsa05033 | 0.08063472 |
| 115 | GABAergic synapse_Homo sapiens_hsa04727 | 0.07483470 |
| 116 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.06381665 |
| 117 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.03419850 |
| 118 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.02958052 |
| 119 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.02885678 |
| 120 | Circadian rhythm_Homo sapiens_hsa04710 | 0.02572554 |
| 121 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.02092094 |
| 122 | Taste transduction_Homo sapiens_hsa04742 | 0.01909036 |
| 123 | Insulin secretion_Homo sapiens_hsa04911 | 0.01690732 |
| 124 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | -0.0375875 |
| 125 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.0358189 |
| 126 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | -0.0090511 |

